Jan Skvarka is a director of Zentalis Pharmaceuticals Inc.
Person profile
Roles
Zentalis Pharmaceuticals
Director
Monte Rosa Therapeutics
Director
Address
Mississauga, Ontario, Canada
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Zentalis Pharmaceuticals, Inc.
13 Sep 23
144
Zentalis Pharmaceuticals, Inc.
11 Sep 23
4
Zentalis Pharmaceuticals, Inc.
16 Jun 23
4
Monte Rosa Therapeutics, Inc.
15 Jun 23
4
Monte Rosa Therapeutics, Inc.
31 Mar 23
3
Monte Rosa Therapeutics, Inc.
24 Mar 23
4
Zentalis Pharmaceuticals, Inc.
12 Sep 22
3
Zentalis Pharmaceuticals, Inc.
12 Sep 22
4
Trillium Therapeutics Inc.
19 Nov 21
4
Trillium Therapeutics Inc.
13 May 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Sep 23 | ZNTL Zentalis Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 25.0475 | 5,000 | 125.24 k | 47,970 |
16 Jun 23 | ZNTL Zentalis Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 16,364 | 0.00 | 52,970 |
14 Jun 23 | GLUE Monte Rosa Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 6.59 | 20,500 | 135.10 k | 20,500 |
30 Mar 23 | GLUE Monte Rosa Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 7.36 | 41,000 | 301.76 k | 41,000 |